Trials / Completed
CompletedNCT03871543
Late Night Study 2: End-of-Day Assessment of Asymptomatic and Symptomatic Soft Lens Wearers
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 196 (actual)
- Sponsor
- Johnson & Johnson Vision Care, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
This is a 2-Part, 8-Visit, single-center, open-label, bilateral and dispensing clinical study. In Part 1 (Visits 1-4) all subjects will be Test Lens 1, in Part 2 (Visits 1-4) eligible subjects will be dispensed Test Lens 2 based on their responses to the CLDEQ-8 questionnaire. Subjects scoring between 11 and 19 on the CLDEQ will not continue into Part 2
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | AquaComfort Plus | Test Lens 1 |
| DEVICE | Acuvue Oasys 1-Day | Test Lens 2 |
Timeline
- Start date
- 2019-04-01
- Primary completion
- 2022-02-03
- Completion
- 2022-02-03
- First posted
- 2019-03-12
- Last updated
- 2023-05-16
- Results posted
- 2023-05-16
Locations
1 site across 1 country: United Kingdom
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03871543. Inclusion in this directory is not an endorsement.